Literature DB >> 2603895

Central hemodynamic assessment of normal term pregnancy.

S L Clark1, D B Cotton, W Lee, C Bishop, T Hill, J Southwick, J Pivarnik, T Spillman, G R DeVore, J Phelan.   

Abstract

Ten carefully screened primiparous patients between 36 and 38 weeks' gestation underwent pulmonary artery catheterization, arterial line placement, and central hemodynamic assessment in the left lateral recumbent position. Studies were repeated in the same patients between 11 and 13 weeks post partum. Compared with the nonpregnant state, there was a significant fall in systemic vascular resistance, pulmonary vascular resistance, colloid oncotic pressure, and colloid oncotic pressure-pulmonary capillary wedge pressure gradient by the late phase of the third trimester (p less than 0.05). Pregnancy was associated with a significant rise in cardiac output and pulse in all patients (p less than 0.05). There was no significant change in pulmonary capillary wedge pressure, central venous pressure, left ventricular stroke work index, or mean arterial pressure. Normally the late phase of the third trimester is not associated with hyperdynamic left ventricular function as assessed by the left ventricular stroke work index/pulmonary capillary wedge pressure ratio.

Entities:  

Mesh:

Year:  1989        PMID: 2603895     DOI: 10.1016/0002-9378(89)90900-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  65 in total

Review 1.  Asthma in the hospitalized obstetrical patient.

Authors:  A M Seyal
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

2.  Guidelines of the American College of Obstetricians and Gynecologists for exercise during pregnancy and the postpartum period.

Authors:  R Artal; M O'Toole
Journal:  Br J Sports Med       Date:  2003-02       Impact factor: 13.800

Review 3.  Adaptation of the maternal heart in pregnancy.

Authors:  S Hunter; S C Robson
Journal:  Br Heart J       Date:  1992-12

4.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

5.  Cardiac hemodynamics before, during and after elective cesarean section under spinal anesthesia in low-risk women.

Authors:  M Ram; A Lavie; S Lev; Y Blecher; U Amikam; Y Shulman; T Avnon; E Weiner; A Many
Journal:  J Perinatol       Date:  2017-04-13       Impact factor: 2.521

Review 6.  Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.

Authors:  André Dallmann; Ibrahim Ince; Michaela Meyer; Stefan Willmann; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2017-11       Impact factor: 6.447

7.  Cardiac surgery during pregnancy.

Authors:  Anish Patel; Sanjay Asopa; Augustine T M Tang; Sunil K Ohri
Journal:  Tex Heart Inst J       Date:  2008

Review 8.  Pathophysiology of pre-eclampsia: update on the role of nitric oxide.

Authors:  Maki Kashiwagi; Roland Zimmermann; Ernst Beinder
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

9.  Pregnancy-specific transcriptional changes upon endotoxin exposure in mice.

Authors:  Kenichiro Motomura; Roberto Romero; Adi L Tarca; Jose Galaz; Gaurav Bhatti; Bogdan Done; Marcia Arenas-Hernandez; Dustyn Levenson; Rebecca Slutsky; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  J Perinat Med       Date:  2020-09-25       Impact factor: 1.901

10.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

Authors:  J W Adams; Y Sakata; M G Davis; V P Sah; Y Wang; S B Liggett; K R Chien; J H Brown; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.